Global Pharmaceuticals & Medicine Manufacturing - Industry Market Research Report

Global Pharmaceuticals & Medicine Manufacturing

Over the five years to 2017, pharmaceutical manufacturers have benefited from an aging population in developed economies and a growing middle class in emerging economies, which provided a larger customer base for industry operators. Many manufacturers also tapped into regional demand for pharmaceuticals that may differ from developed markets, such as higher rates of gastric and esophageal cancer in East Asia. Furthermore, the growing global middle class provides additional growth opportunities, given increased access to pharmaceutical products and higher per capita expenditure on medicines. Over the five years to 2022, industry revenue is forecast to grow as more pharmaceutical manufacturers tailor their R&D and product portfolio to meet emerging markets' healthcare needs.

This industry comprises companies that manufacture biological, medicinal and pharmaceutical products in various forms, including ampoules, tablets, capsules, vials, ointments, powders, solutions and suspensions. The overall pharmaceutical market can be segmented into prescription-based (or ethical) products and over-the-counter medications. Industry products are predominantly distributed via wholesalers, and are then sold via pharmacies or distributed in hospitals.

This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.